ClinicalTrials.Veeva

Menu

Standing Cognition and Co-morbidities of POTS Evaluation (SCOPE)

Penn State Health logo

Penn State Health

Status

Completed

Conditions

Ehlers-Danlos Syndrome
Postural Tachycardia Syndrome

Treatments

Behavioral: Supine
Behavioral: Standing

Study type

Interventional

Funder types

Other

Identifiers

NCT03602482
Study00009606

Details and patient eligibility

About

The purpose of this study is to evaluate cognition in patients with postural tachycardia syndrome (POTS) while lying down and standing and to assess the prevalence of hypermobile Ehlers-Danlos Syndrome in POTS.

Enrollment

139 patients

Sex

All

Ages

13 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Previously diagnosed with POTS, or healthy control
  • Age between 13-60 years
  • Participants may be any race, ethnicity, sex, or gender
  • Able and willing to provide informed consent

Exclusion criteria

  • Inability to give, or withdrawal of, informed consent
  • Age ≤ 13 or ≥ 61 years
  • Prisoners
  • Unable to stand

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

139 participants in 2 patient groups

Standing
Experimental group
Description:
Participants will complete cognitive testing while standing.
Treatment:
Behavioral: Standing
Supine
Active Comparator group
Description:
Participants will complete cognitive testing while supine.
Treatment:
Behavioral: Supine

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems